Prohibiting Abortion Industry’s Lucrative Loopholes Act

H.R. 727 would amend federal law to establish stricter prohibitions on financial transactions related to human fetal tissue. Currently, federal law since 1993 has prohibited abortion providers from profiting directly from the sale of fetal tissue, but the bill would address what its supporters characterize as loopholes that allow reimbursements for processing, storage, and shipping fees. The bill would apply to fetal tissue used by universities, laboratories, and other research institutions for scientific purposes. If enacted, the legislation would modify how these transactions are regulated and potentially limit the types of fees that can be charged in connection with fetal tissue transfers. The bill is currently in the House Committee on Energy and Commerce and has not yet been voted on by the full House.